Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Shares Shorted: Short Interest Down 73.5% in September

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a significant decline in short interest in the month of September. As of September 15th, there was short interest totaling 7,633 shares, a decline of 73.5% from the August 31st total of 28,773 shares. Based on an average daily volume of 42,981 shares, the short-interest ratio is presently 0.2 days. Currently, 0.2% of the company’s shares are sold short.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Bank of America Corp DE increased its stake in Invesco Pharmaceuticals ETF by 234.0% during the first quarter. Bank of America Corp DE now owns 74,458 shares of the company’s stock worth $7,726,000 after acquiring an additional 52,165 shares during the last quarter. Royal Bank of Canada lifted its stake in shares of Invesco Pharmaceuticals ETF by 479.8% in the 1st quarter. Royal Bank of Canada now owns 62,377 shares of the company’s stock valued at $6,472,000 after purchasing an additional 51,619 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in shares of Invesco Pharmaceuticals ETF by 35.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 36,897 shares of the company’s stock valued at $4,370,000 after purchasing an additional 9,741 shares during the last quarter. Cetera Investment Advisers grew its holdings in shares of Invesco Pharmaceuticals ETF by 250.7% during the 1st quarter. Cetera Investment Advisers now owns 20,462 shares of the company’s stock worth $2,123,000 after purchasing an additional 14,628 shares during the period. Finally, Gilpin Wealth Management LLC purchased a new position in shares of Invesco Pharmaceuticals ETF during the 4th quarter worth $735,000.

Invesco Pharmaceuticals ETF Stock Up 0.2%

NYSEARCA:PJP traded up $0.29 on Monday, hitting $127.11. The stock had a trading volume of 16,898 shares, compared to its average volume of 35,751. The company has a fifty day moving average price of $125.49 and a two-hundred day moving average price of $114.65. Invesco Pharmaceuticals ETF has a 1-year low of $90.43 and a 1-year high of $131.68. The stock has a market cap of $569.45 million, a price-to-earnings ratio of 15.59 and a beta of 0.45.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.